478 related articles for article (PubMed ID: 6276928)
21. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
22. Anti-poliomyelitis campaign in Taiwan.
Hsu ST; Lin SY
Southeast Asian J Trop Med Public Health; 1971 Jun; 2(2):140-6. PubMed ID: 4332824
[No Abstract] [Full Text] [Related]
23. Poliomyelitis vaccination for the international traveler.
Mann JM; Bernier RH; Hinman AR
Am Fam Physician; 1982 Dec; 26(6):135-9. PubMed ID: 7148637
[TBL] [Abstract][Full Text] [Related]
24. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
25. Poliomyelitis vaccines: an appraisal after 25 years.
Melnick JL
Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
[No Abstract] [Full Text] [Related]
26. Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013.
Wkly Epidemiol Rec; 2014 Mar; 89(12):127-32. PubMed ID: 24707518
[No Abstract] [Full Text] [Related]
27. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
Lamy ME; Cornu C; Desmyter J
Dev Biol Stand; 1979; 43():207-13. PubMed ID: 230111
[TBL] [Abstract][Full Text] [Related]
28. Poliomyelitis vaccination. Evaluation and direction in continuing application.
Sabin AB
Am J Clin Pathol; 1978 Jul; 70(1 Suppl):136-40. PubMed ID: 210653
[No Abstract] [Full Text] [Related]
29. [Serological and epidemiological effects of Sabin oral vaccination against poliomyelitis in Tyrol].
Bauer P
Arch Hyg Bakteriol; 1968 Dec; 152(5):405-9. PubMed ID: 5741512
[No Abstract] [Full Text] [Related]
30. [Indicators of immunity in children vaccinated with live poliomyelitis vaccine].
Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):115-7. PubMed ID: 204133
[TBL] [Abstract][Full Text] [Related]
31. [Levels of specific antibodies against poliomyelitis virus and degree of immune protection in Umbria population].
Stagni G; Merletti L; De Rosa F
Boll Ist Sieroter Milan; 1979 Jul; 58(3):210-5. PubMed ID: 229884
[TBL] [Abstract][Full Text] [Related]
32. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3.
Böthig B; Danes L; Dittmann S
Bull World Health Organ; 1990; 68(5):597-600. PubMed ID: 1963118
[TBL] [Abstract][Full Text] [Related]
34. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
[TBL] [Abstract][Full Text] [Related]
35. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso.
Rümke HC
Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056
[No Abstract] [Full Text] [Related]
36. [Epidemiology of poliomyelitis in Belgium].
Walckiers D; Stroobant A; Lamotte JM; Thiers G
Arch Belg; 1983; 41(7-8):341-54. PubMed ID: 6673667
[No Abstract] [Full Text] [Related]
37. [A poliomyelitis epidemic caused by poliovirus type 3 in the region of Poznan in 1968. Preliminary communication].
Walter T
Zentralbl Bakteriol Orig; 1968; 209(1):134-7. PubMed ID: 4318103
[No Abstract] [Full Text] [Related]
38. Poliomyelitis immunity status in Italian and foreign subjects.
Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
[No Abstract] [Full Text] [Related]
39. 2001 serological survey in the Czech Republic--poliomyelitis.
Matyásová I; Rainetová P; Cástková J
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
[TBL] [Abstract][Full Text] [Related]
40. Epidemiological surveillance and control of poliomyelitis in the Republic of Cuba.
Ochoa EG; Lago PM
J Hyg Epidemiol Microbiol Immunol; 1987; 31(4):381-9. PubMed ID: 2828465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
